Dyslipidemia in pregnancy induced hypertension

Adiga Usha, Adiga Sachidananda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Pregnancy induced hypertension (PIH) is one of the commonest complications of pregnancy of our study is to assess the atherogenic index of PIH patients as compared to normal pregnant women also to compare the same between preeclamptic and eclamptic patients. Blood samples from thirty five PIH subjects and 25 normal pregnant women were collected for the study. Total cholesterol (TC) and HDL-C estimated. Atherogenic index (AI), TC/HDL-C was calculated.TC value of control group was 203.0 ± 20.37mg/dl and that of patients was 256.34 ± 32.78 mg/dl. HDL-C levels observed in patients was 42.12 ± 6.34mg/dl and 66.33 ± 4.73 mg/dl in controls. No statistically significant difference in the values was found between preeclamptics and eclamptics. Atherogenic index was significantly high in PIH patients. Disorders of the lipoprotein metabolisms occuring in PIH may be responsible for the fatty deposition in the vessel walls. This may predispose them for coronary heart disease in future. These patients should be followed up after delivery to see whether the lipid levels return to normal or these changes are permanent. Further studies need to be done to find the cause of the dyslipidemia at the genetic level.

Original languageEnglish
Pages (from-to)69-72
Number of pages4
JournalJournal of Global Pharma Technology
Volume2
Issue number5
Publication statusPublished - 01-05-2010
Externally publishedYes

Fingerprint

Pregnancy Induced Hypertension
Dyslipidemias
HDL Cholesterol
Pregnant Women
Pregnancy Complications
Lipoproteins
Coronary Disease
Cholesterol
Lipids
Control Groups

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Usha, A., & Sachidananda, A. (2010). Dyslipidemia in pregnancy induced hypertension. Journal of Global Pharma Technology, 2(5), 69-72.
Usha, Adiga ; Sachidananda, Adiga. / Dyslipidemia in pregnancy induced hypertension. In: Journal of Global Pharma Technology. 2010 ; Vol. 2, No. 5. pp. 69-72.
@article{79ebe2cf94b74e2f972306b9d835644c,
title = "Dyslipidemia in pregnancy induced hypertension",
abstract = "Pregnancy induced hypertension (PIH) is one of the commonest complications of pregnancy of our study is to assess the atherogenic index of PIH patients as compared to normal pregnant women also to compare the same between preeclamptic and eclamptic patients. Blood samples from thirty five PIH subjects and 25 normal pregnant women were collected for the study. Total cholesterol (TC) and HDL-C estimated. Atherogenic index (AI), TC/HDL-C was calculated.TC value of control group was 203.0 ± 20.37mg/dl and that of patients was 256.34 ± 32.78 mg/dl. HDL-C levels observed in patients was 42.12 ± 6.34mg/dl and 66.33 ± 4.73 mg/dl in controls. No statistically significant difference in the values was found between preeclamptics and eclamptics. Atherogenic index was significantly high in PIH patients. Disorders of the lipoprotein metabolisms occuring in PIH may be responsible for the fatty deposition in the vessel walls. This may predispose them for coronary heart disease in future. These patients should be followed up after delivery to see whether the lipid levels return to normal or these changes are permanent. Further studies need to be done to find the cause of the dyslipidemia at the genetic level.",
author = "Adiga Usha and Adiga Sachidananda",
year = "2010",
month = "5",
day = "1",
language = "English",
volume = "2",
pages = "69--72",
journal = "Journal of Global Pharma Technology",
issn = "0975-8542",
publisher = "Journal of Global Pharma Technology",
number = "5",

}

Usha, A & Sachidananda, A 2010, 'Dyslipidemia in pregnancy induced hypertension', Journal of Global Pharma Technology, vol. 2, no. 5, pp. 69-72.

Dyslipidemia in pregnancy induced hypertension. / Usha, Adiga; Sachidananda, Adiga.

In: Journal of Global Pharma Technology, Vol. 2, No. 5, 01.05.2010, p. 69-72.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dyslipidemia in pregnancy induced hypertension

AU - Usha, Adiga

AU - Sachidananda, Adiga

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Pregnancy induced hypertension (PIH) is one of the commonest complications of pregnancy of our study is to assess the atherogenic index of PIH patients as compared to normal pregnant women also to compare the same between preeclamptic and eclamptic patients. Blood samples from thirty five PIH subjects and 25 normal pregnant women were collected for the study. Total cholesterol (TC) and HDL-C estimated. Atherogenic index (AI), TC/HDL-C was calculated.TC value of control group was 203.0 ± 20.37mg/dl and that of patients was 256.34 ± 32.78 mg/dl. HDL-C levels observed in patients was 42.12 ± 6.34mg/dl and 66.33 ± 4.73 mg/dl in controls. No statistically significant difference in the values was found between preeclamptics and eclamptics. Atherogenic index was significantly high in PIH patients. Disorders of the lipoprotein metabolisms occuring in PIH may be responsible for the fatty deposition in the vessel walls. This may predispose them for coronary heart disease in future. These patients should be followed up after delivery to see whether the lipid levels return to normal or these changes are permanent. Further studies need to be done to find the cause of the dyslipidemia at the genetic level.

AB - Pregnancy induced hypertension (PIH) is one of the commonest complications of pregnancy of our study is to assess the atherogenic index of PIH patients as compared to normal pregnant women also to compare the same between preeclamptic and eclamptic patients. Blood samples from thirty five PIH subjects and 25 normal pregnant women were collected for the study. Total cholesterol (TC) and HDL-C estimated. Atherogenic index (AI), TC/HDL-C was calculated.TC value of control group was 203.0 ± 20.37mg/dl and that of patients was 256.34 ± 32.78 mg/dl. HDL-C levels observed in patients was 42.12 ± 6.34mg/dl and 66.33 ± 4.73 mg/dl in controls. No statistically significant difference in the values was found between preeclamptics and eclamptics. Atherogenic index was significantly high in PIH patients. Disorders of the lipoprotein metabolisms occuring in PIH may be responsible for the fatty deposition in the vessel walls. This may predispose them for coronary heart disease in future. These patients should be followed up after delivery to see whether the lipid levels return to normal or these changes are permanent. Further studies need to be done to find the cause of the dyslipidemia at the genetic level.

UR - http://www.scopus.com/inward/record.url?scp=79952643185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952643185&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79952643185

VL - 2

SP - 69

EP - 72

JO - Journal of Global Pharma Technology

JF - Journal of Global Pharma Technology

SN - 0975-8542

IS - 5

ER -